Blood pressure components and end-stage renal disease in persons with chronic kidney disease: The Kidney Early Evaluation Program (KEEP)

Archives of Internal Medicine

Volumn 172, Issue 1, 2012, Pages 41-47

  Peralta, Carmen A ^a,b   Norris, Keith C ^c   Li, Suying ^d   Chang, Tara I ^e   Tamura, Manjula K ^e   Jolly, Stacey E ^f   Bakris, George ^g   McCullough, Peter A ^h   Shlipak, Michael ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h St John Providence Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEALTH PROGRAM; HISPANIC; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SEX; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ALBUMINURIA; DIASTOLE; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK ASSESSMENT; SYSTOLE; UNITED STATES;

EID: 84862910560     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.619     Document Type: Article

References (29)

1. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5)(suppl 1):S1-S290.
2. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for endstage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342- 350.
3. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA. 1997;277(16):1293-1298. (Pubitemid 27194353)
4. Jafar TH, Stark PC, Schmid CH, et al AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003; 139(4):244-252.
5. Klahr S, Levey AS, Beck GJ, et al Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330(13):877-884. (Pubitemid 24094966)
6. Appel LJ, Wright JT Jr, Greene T, et al AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918-929.
7. Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study. Ann Intern Med. 2005;142(5):342-351. (Pubitemid 40293407)
8. Upadhyay A, Earley A, Haynes SM, Uhlig K. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154(8):541-548.
9. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6):1119-1124. (Pubitemid 40770315)
10. Duru OK, Li S, Jurkovitz C, et al. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008;51(2):192-198.
11. Peralta CA, Shlipak MG, Wassel-Fyr CL, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007; 50(3):474-480. (Pubitemid 47312232)
12. Wright JT Jr, Agodoa L, Contreras G, et al African American Study of Kidney Disease and Hypertension Study Group. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med. 2002;162(14):1636-1643. (Pubitemid 34765014)
13. Hebert LA, Kusek JW, Greene T, et al Modification of Diet in Renal Disease Study Group. Effects of blood pressure control on progressive renal disease in blacks and whites. Hypertension. 1997;30(3, pt 1):428-435. (Pubitemid 27446104)
14. Townsend RR, Wimmer NJ, Chirinos JA, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010;23(3):282-289.
15. Franklin SS, Lopez VA, Wong ND, et al. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119(2):243-250.
16. Berl T, Hunsicker LG, Lewis JB, et al Collaborative Study Group. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16(7):2170-2179. (Pubitemid 41716450)
17. Bakris GL, Weir MR, Shanifar S, et al RENAAL Study Group. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163(13):1555-1565. (Pubitemid 36835100)
18. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):830-837.
19. Reynolds K, Gu D, Muntner P, et al. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007;18(6):1928-1935. (Pubitemid 46870330)
20. Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW. The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis. 2008;51(4)(suppl 2):S3-S12. (Pubitemid 351417312)
21. Levey AS, Stevens LA, Schmid CH, et al CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
22. Chobanian AV, Bakris GL, Black HR, et al National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572. (Pubitemid 37430158)
23. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884-893. (Pubitemid 46768128)
24. Sarafidis PA, Riehle J, Bogojevic Z, Basta E, Chugh A, Bakris GL. A comparative evaluation of various methods for microalbuminuria screening. Am J Nephrol. 2008;28(2):324-329.
25. Le Floch JP, Marre M, Rodier M, Passa P. Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. Diabetes Metab. 2001;27(1):36-39. (Pubitemid 32198878)
26. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123(10):754-762.
27. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002;13(11):2776-2782. (Pubitemid 35216048)
28. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? the Framingham heart study. Circulation. 1999;100(4):354-360. (Pubitemid 29362404)
29. Staessen JA, Asmar R, De Buyzere M, et al Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit. 2001; 6(6):355-370. (Pubitemid 34194893)